Provident Trust Company’s MetLife MET Stock Holding History

Provident Trust Company’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,329	Closed	-$205K	–	35
2021 Q3	$205K	Buy	+3,329	New	+$200K	﹤0.01%	35

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Provident Trust Company's MET Position: Q4 2021 in Review

Provident Trust Company sold out of MetLife (MET) in Q4 2021, closing a stake of 3,329 shares — an estimated $205K sold.

Provident Trust Company first reported a position in MET in Q3 2021 and held it in 1 quarter. The position peaked at $205K in Q3 2021. 1,193 funds tracked by Wall St. Rank hold MET as of Q4 2021.

Provident Trust Company reported no remaining MetLife position as of Q4 2021 after selling out during the quarter.
Provident Trust Company sold 3,329 MetLife shares in Q4 2021, an estimated $205K.
Provident Trust Company first reported a position in MetLife in Q3 2021 and held it in 1 quarter.
Provident Trust Company's MetLife position peaked at $205K in Q3 2021.
1,193 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on Provident Trust Company's 13F filing for Q4 2021, filed 4 Feb 2022.